Skip to main content
Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.92
-0.15 (-1.86%)
At close: Apr 28, 2026, 4:00 PM EDT
7.97
+0.05 (0.63%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Novavax Employees

Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.

Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$1,499,972
Profits / Employee
$587,853
Market Cap
1.29B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025749-203-21.32%
Dec 31, 2024952-591-38.30%
Dec 31, 20231,543-449-22.54%
Dec 31, 20221,99245129.27%
Dec 31, 20211,54174994.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Iovance Biotherapeutics 975
AbCellera Biologics 562
Wave Life Sciences 317
Viridian Therapeutics 252
Maze Therapeutics 141
MapLight Therapeutics 133
Olema Pharmaceuticals 131
ArriVent BioPharma 77
Employee Rankings

NVAX News

More News